{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:05Z","timestamp":1792786145391,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","funder":[{"name":"Ningbo Top Medical and Health Research Program","award":["2023010211"],"award-info":[{"award-number":["2023010211"]}]},{"name":"Ningbo Municipal Key Medical Discipline (Western Medicine) Development Project","award":["2026-A40"],"award-info":[{"award-number":["2026-A40"]}]},{"name":"Zhejiang Provincial Medicine and Health Research Foundation","award":["WKJ-ZJ-26087"],"award-info":[{"award-number":["WKJ-ZJ-26087"]}]},{"name":"Public Welfare Science and Technology Plan Project of Ningbo","award":["2023S060"],"award-info":[{"award-number":["2023S060"]}]},{"name":"Wu Jieping Medical Foundation Scientific Research Grant","award":["320.6750.2025-24-2"],"award-info":[{"award-number":["320.6750.2025-24-2"]}],"id":[{"id":"https:\/\/ror.org\/05dgwj702","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Metanephric adenoma (MA) is a rare benign renal neoplasm characterized by recurrent\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    V600E mutations in \u223c80% to 90% of cases. The molecular drivers in\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    V600E\u2011negative MAs remain poorly understood, although rare kinase fusions have been reported. Here, we present a multi\u2011institutional series of 7\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    V600E\u2011negative MAs with confirmed kinase fusions. The patients included 5 women and 2 men, with a median age of 43 years (range: 24 to 62\u00a0y). All tumors were uncapsulated and exhibited typical MA histology. Notably, leaf\u2011like structures formed by branching dilated tubules surrounding dense small acini were observed in 4 of 7 cases, and thyroid follicle\u2011like structures and\/or microcystic\/reticular patterns were observed in 3 of 7 cases. The majority of cases showed marked paucity of edematous or fibrous stroma. By immunohistochemistry, all cases were diffusely positive for WT1 and CD57, negative for BRAF V600E (clone VE1), and largely negative for CK7 and AMACR. Targeted RNA sequencing identified fusions involving\n                    <jats:italic toggle=\"yes\">RET<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">CCDC6<\/jats:italic>\n                    ::\n                    <jats:italic toggle=\"yes\">RET<\/jats:italic>\n                    in 2 cases,\n                    <jats:italic toggle=\"yes\">ANKRD26<\/jats:italic>\n                    ::\n                    <jats:italic toggle=\"yes\">RET<\/jats:italic>\n                    in 1),\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">STRN<\/jats:italic>\n                    ::\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    in 2),\n                    <jats:italic toggle=\"yes\">ROS1<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">RDX<\/jats:italic>\n                    ::\n                    <jats:italic toggle=\"yes\">ROS1<\/jats:italic>\n                    in 1), and\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">CUX1<\/jats:italic>\n                    ::\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    in 1). All fusions preserved the kinase domain of the respective genes. Fluorescence in situ hybridization or reverse\u2011transcriptase PCR confirmed the rearrangements in available cases. In contrast, targeted RNA sequencing of 7\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    V600E\u2011mutant MAs revealed no kinase fusions. All patients underwent partial nephrectomy and remained disease\u2011free during follow\u2011up (median: 18\u00a0mo, range: 14 to 115\u00a0mo). Our findings demonstrate that kinase fusions, including\n                    <jats:italic toggle=\"yes\">RET<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ROS1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    , represent alternative drivers in\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    V600E\u2011negative MAs, expanding the molecular spectrum of MA. In VE1-negative cases with classic MA histology, targeted RNA sequencing for these fusions may serve as a useful diagnostic adjunct.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002604","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:00:24Z","timestamp":1787637624000},"page":"1342-1351","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Kinase Fusions Define a Distinct Subset of BRAF V600E\u2011Negative Metanephric Adenomas"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-7303","authenticated-orcid":false,"given":"Ming","family":"Zhao","sequence":"first","affiliation":[{"name":"Ningbo Clinical Pathology Diagnosis Center, Ningbo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital of Shanghai Jiaotong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Institute of Pathology, Shanghai Medical College, Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fang","sequence":"additional","affiliation":[{"name":"Ningbo Clinical Pathology Diagnosis Center, Ningbo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Xu","sequence":"additional","affiliation":[{"name":"Ningbo Clinical Pathology Diagnosis Center, Ningbo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimiao","family":"Qiu","sequence":"additional","affiliation":[{"name":"Ningbo Clinical Pathology Diagnosis Center, Ningbo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ningbo Clinical Pathology Diagnosis Center, Ningbo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Basic Medical Sciences, Third Hospital, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"R1-20261014","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00000478-199510000-00001","article-title":"Metanephric adenoma. Clinicopathological study of fifty patients","volume":"19","author":"Davis","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R2-20261014","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00000478-199506000-00001","article-title":"Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases","volume":"19","author":"Jones","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R3-20261014","first-page":"41","article-title":"Papillary and metanephric adenomas of the kidney","volume":"15","author":"Grignon","year":"1998","journal-title":"Semin Diagn Pathol"},{"key":"R4-20261014","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/00000478-200110000-00010","article-title":"Metanephric adenoma, nephrogenic rests, and Wilms\u2019 tumor: a histologic and immunophenotypic comparison","volume":"25","author":"Muir","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R5-20261014","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/modpathol.3800520","article-title":"Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma","volume":"19","author":"Olgac","year":"2006","journal-title":"Mod Pathol"},{"key":"R6-20261014","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/modpathol.2015.81","article-title":"Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma","volume":"28","author":"Kinney","year":"2015","journal-title":"Mod Pathol"},{"key":"R7-20261014","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eururo.2012.05.051","article-title":"BRAF mutations in metanephric adenoma of the kidney","volume":"62","author":"Choueiri","year":"2012","journal-title":"Eur Urol"},{"key":"R8-20261014","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/PAS.0000000000000377","article-title":"Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma","volume":"39","author":"Udager","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R9-20261014","doi-asserted-by":"crossref","first-page":"54096","DOI":"10.18632\/oncotarget.11117","article-title":"Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation","volume":"8","author":"Cali\u00f2","year":"2016","journal-title":"Oncotarget"},{"key":"R10-20261014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-018-0732-x","article-title":"Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases","volume":"13","author":"Ding","year":"2018","journal-title":"Diagn Pathol"},{"key":"R11-20261014","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/his.12509","article-title":"Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma","volume":"66","author":"Pinto","year":"2015","journal-title":"Histopathology"},{"key":"R12-20261014","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12881-020-01143-6","article-title":"KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas","volume":"21","author":"Catic","year":"2020","journal-title":"BMC Med Genet"},{"key":"R13-20261014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cancergen.2017.03.001","article-title":"A novel cytogenetic and molecular characterization of renal metanephric adenoma: identification of partner genes involved in translocation t(9;15)(p24;q24)","volume":"214-215","author":"Catic","year":"2017","journal-title":"Cancer Genet"},{"key":"R15-20261014","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/ijc.31106","article-title":"CCDC6: the identity of a protein known to be partner in fusion","volume":"142","author":"Cerrato","year":"2018","journal-title":"Int J Cancer"},{"key":"R16-20261014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cancergen.2019.07.002","article-title":"ANKRD26-RET\u2014a novel gene fusion involving RET in papillary thyroid carcinoma","volume":"238","author":"Staubitz","year":"2019","journal-title":"Cancer Genet"},{"key":"R17-20261014","first-page":"100100","article-title":"Correlating ROS1 protein expression with ROS1 fusions, amplifications, and mutations","volume":"2","author":"Huang","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"R18-20261014","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PAS.0000000000000610","article-title":"Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene","volume":"40","author":"Kusano","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R19-20261014","doi-asserted-by":"crossref","first-page":"100536","DOI":"10.1016\/j.modpat.2024.100536","article-title":"ALK-rearranged renal cell carcinoma: a multi-institutional study of 9 cases with expanding the morphologic and molecular genetic spectrum","volume":"37","author":"Zhao","year":"2024","journal-title":"Mod Pathol"},{"key":"R20-20261014","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/EJE-17-0499","article-title":"ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population","volume":"178","author":"Bastos","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"R21-20261014","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","article-title":"ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217","volume":"33","author":"Kuroda","year":"2020","journal-title":"Mod Pathol"},{"key":"R22-20261014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gene.2012.01.039","article-title":"CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases","volume":"497","author":"Hulea","year":"2012","journal-title":"Gene"},{"key":"R23-20261014","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00428-020-02752-5","article-title":"ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology","volume":"476","author":"Hang","year":"2020","journal-title":"Virchows Arch"},{"key":"R24-20261014","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/PAS.0000000000001240","article-title":"Metanephric adenoma-epithelial Wilms tumor overlap lesions: an analysis of BRAF status","volume":"43","author":"Wobker","year":"2019","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:00:15Z","timestamp":1791961215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002604"}},"subtitle":["A Multi-Institutional Study of 7 Cases"],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002604","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"2026-06-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}